Jay Pepose - 07 Jun 2021 Form 3 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
Director
Signature
/s/ Emily J. Johns, by Power of Attorney
Issuer symbol
IRD
Transactions as of
07 Jun 2021
Net transactions value
$0
Form type
3
Filing time
09 Jun 2021, 17:19:26 UTC
Next filing
15 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OCUP Common Stock 2,113 07 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCUP Stock Option (right to buy) 07 Jun 2021 Common Stock 4,226 $1.15 Direct F1
holding OCUP Stock Option (right to buy) 07 Jun 2021 Common Stock 10,565 $1.65 Direct F1
holding OCUP Stock Option (right to buy) 07 Jun 2021 Common Stock 30,000 $4.05 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are fully vested.
F2 625 shares vesting on the last day of each month from November 2020 to October 2024 with the balance vesting in the last month, subject to the Reporting Person's continuing service through the vesting date.

Remarks:

Exhibit 24, Power of Attorney, is attached.